Thomas H. Silberg
Voorzitter bij GenWay Biotech, Inc.
Profiel
Thomas H.
Silberg currently works at GenWay Biotech, Inc., as Chairman.
Mr. Silberg also formerly worked at APP Pharmaceuticals, Inc., as President & Chief Executive Officer from 2006 to 2009, Fresenius Kabi Pharmaceuticals Holding LLC, as President & Chief Executive Officer in 2009, Cobalis Corp., as Director, Ligand Pharmaceuticals, Inc., as Chief Operating Officer & Executive Vice President from 2000 to 2003, Tercica, Inc., as Chief Operating Officer from 2004 to 2005, Hoffmann-La Roche, Inc., as Vice President-Business Operations, Abraxis BioScience, Inc., as Executive Vice President from 2006 to 2007, and Abraxis Pharmaceutical Products, as President from 2006 to 2007.
Mr. Silberg received his undergraduate degree from the University of Minnesota.
Actieve functies van Thomas H. Silberg
Bedrijven | Functie | Begin |
---|---|---|
GenWay Biotech, Inc.
GenWay Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services GenWay Biotech, Inc. operates as protein and antibody solutions provider. The firm has a proprietary technology platform and an international network to provide its clients with solutions and applications for proteins, antibodies, assays and cell lines. It specializes in recombinant proteins and domain-specific IgY (chicken) antibodies and its applications, such as Seppro products and difficult-to-express proteins. The company was founded by Wei-Wei Zhang in 1998 and is headquartered in San Diego, CA. | Voorzitter | - |
Eerdere bekende functies van Thomas H. Silberg
Bedrijven | Functie | Einde |
---|---|---|
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | President | 31-12-2009 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | President | 31-12-2009 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Corporate Officer/Principal | 15-11-2007 |
Abraxis Pharmaceutical Products
Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | President | 01-11-2007 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Operationeel Directeur | 01-06-2005 |
Opleiding van Thomas H. Silberg
University of Minnesota | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Cobalis Corp.
Cobalis Corp. Pharmaceuticals: OtherHealth Technology Cobalis Corp. is a pharmaceutical and nutraceutical company. Its flagship product, PreHistin designs to prevent the primary causes of airborne allergies. Cobalis specializes in the development of anti allergy medications. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
GenWay Biotech, Inc.
GenWay Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services GenWay Biotech, Inc. operates as protein and antibody solutions provider. The firm has a proprietary technology platform and an international network to provide its clients with solutions and applications for proteins, antibodies, assays and cell lines. It specializes in recombinant proteins and domain-specific IgY (chicken) antibodies and its applications, such as Seppro products and difficult-to-express proteins. The company was founded by Wei-Wei Zhang in 1998 and is headquartered in San Diego, CA. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Abraxis Pharmaceutical Products
Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Health Technology |